Determinants and Effects in the Use of NOHARM Pain Management
Describing the Determinants and Effects of Variation in the Adoption and Use of the NOHARM Pain Management Intervention Among Diverse Surgical Practices
2 other identifiers
observational
372
1 country
1
Brief Summary
The objective of this study is to enrich the ongoing Non-pharmacological Pain Management After Surgery (NOHARM) pragmatic trial (NCT04570371) with a mixed methods analysis of patient and care team factors that affect the routine adoption, implementation, and meaningful and sustainable use of the NOHARM intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2021
CompletedFirst Posted
Study publicly available on registry
December 21, 2021
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedOctober 22, 2025
October 1, 2025
1.9 years
October 28, 2021
October 20, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Aim 1
Characteristics of high and low fidelity users of the intervention
3 months post-surgery
Determinants of patient engagement with the intervention
Measured by the NOHARM patient interview guide that asks the participant to list determinants for non-medication options of managing pain
3 months post-surgery
Sustainability of the NOHARM intervention
Assessed using the Clinical Sustainability Assessment Tool (CSAT) that is a structured assessment of current capacity for sustainability across a range of specific organizational and contextual factors. Responses from the care team for this survey identify sustainability strengths and challenges. Questions use a scale of 1=to little or not extent and 7 = to a very great extent; scores are averaged for a total score with lower average scores indicating areas where practice capacity for sustainability could be improved.
3 months post-surgery
Study Arms (2)
Patients
A sample of patients who received the NOHARM intervention after their surgery.
Care Team Members
Staff members who had patients on the NOHARM intervention
Eligibility Criteria
Participants will all be patients who received the NOHARM intervention for a recent surgery.
You may qualify if:
- Participants eligible for this study will be patients on the NOHARM trial registry (e.g., patients that were automatically assigned to receive the NOHARM intervention as part of their surgical care) and/or their charts and members of their care teams, including nurses, doctors, physical therapists, nurse practitioners and physician assistants, and medical assistants.
You may not qualify if:
- Individuals not on the NOHARM trial registry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Mayo Clinic Rochester
Rochester, Minnesota, 55901, United States
Related Publications (1)
Minteer SA, Audeh CM, Tofthagen C, Sheffield KE, Cutshall SM, Tilburt JC, Cheville AL. Patients' peri-operative experiences with non-pharmacologic pain care techniques: a secondary qualitative analysis of the NOHARM trial. BMC Complement Med Ther. 2025 Oct 17;25(1):388. doi: 10.1186/s12906-025-05141-0.
PMID: 41107758DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Cheville, MD
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 28, 2021
First Posted
December 21, 2021
Study Start
March 1, 2022
Primary Completion
February 1, 2024
Study Completion
February 1, 2024
Last Updated
October 22, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share